German health officials Friday said coronavirus cases in the country are rising at “an exponential rate,” forcing the government to reconsider lifting COVID-19 restrictions. At a news conference in Berlin, Robert Koch Institute ((RKI)) for infectious Diseases Vice President Lars Schaade told reporters highly contagious virus variants were getting the upper hand in the nation, wiping out progress seen last month in containing the pandemic.Shaade, appearing with German Health Minister Jens Spahn, reported 17,482 new infections in the previous 24 hours and 226 deaths in Germany, with the seven-day incidence rate soaring to about 96 per 100,000 people, despite a months-long lockdown in much of the country.Shaade said increased infections were notably among younger people. “The incidence increases are clearly in the groups under 60 years old, especially in the group 15 to 49 years old.”Spahn told reporters the numbers mean plans to re-open the country will need to be put on hold. “On the contrary, we may even have to take steps backwards.”Earlier this month, when German Chancellor Angela Merkel announced plans to gradually lift COVID-19 restrictions, she said she and regional leaders agreed to impose new restrictions in areas where the seven-day incidence rate surpassed 100. At least two regions have already reached that threshold.Meanwhile, Spahn said he has been negotiating with Russia regarding its Sputnik V vaccine, and indicated he is very close to completing a deal. He said the government had been in close contact with the Russians, “and I can also well imagine that we [will] conclude contracts — and conclude them quickly.”He said, however, Germany needs more details on how many doses could be delivered and when. The vaccine has yet to be approved by German or European Union regulators.Germany resumed administering AstraZeneca’s COVID-19 vaccine Thursday after the EU regulator Europe Medincines Agency ((EMA)) concluded once again that it was safe and effective. The agency had conducted a study of the vaccine and cases of blood clots reported in several patients after receiving the vaccine.
…

your ads here!

U.S. President Joe Biden and Vice President Kamala Harris are traveling to the southern U.S. state of Georgia on Friday, responding to the COVID-19 pandemic and the massage parlor shootings near Atlanta on Tuesday.The U.S. leaders will meet with Asian American leaders to discuss the shootings and the targeting of people of Asian descent in the U.S. in apparent hate crimes.Georgia officials, however, have not yet labeled the massage parlor shootings as hate crimes because the suspect said the shooting spree was a result of his sexual issues.The president and the vice president will also meet with officials at the Centers for Disease Control and Prevention while in Georgia to get an update on the U.S.  handling the COVID-19 pandemic.They were originally also planning to participate in a “Help Is Here” rally to promote the trillion-dollar COVID relief package.The rally has been postponed in the wake of the shootings that killed eight people, six of Asian descent. Biden is, however, slated to meet with former gubernatorial candidate Stacey Abrams whose organizing is widely viewed as being responsible for the Democratic presidential win in Georgia in November, the first Democratic presidential victory in the southern state since 1992.Meanwhile, U.S. and Mexican officials deny Washington is attaching any strings to a likely shipment of millions of coronavirus vaccine doses to America’s southern neighbor at a time of heightened migration passing through Mexico en route to the United States.“[P]reventing the spread of a global pandemic is part of one of our diplomatic objectives. Another one of our diplomatic objectives is working to address the challenges at the border. So, it shouldn’t be a surprise that those conversations are both ongoing and happening,” White House press secretary Jen Psaki replied when asked about a link between lending vaccine supplies and commitments from Mexico to tighten the flow of migrants heading north.“These are two separate issues, as we look for a more humane migratory system and enhanced cooperation against COVID-19, for the benefit of our two countries and the region,” said a statement from Roberto Velasco, director general for the North America region at Mexico’s foreign ministry.Sorry, but your browser cannot support embedded video of this type, you can
download this video to view it offline.Download File360p | 10 MB480p | 14 MB540p | 19 MB720p | 37 MB1080p | 74 MBOriginal | 224 MB Embed” />Copy Download AudioPsaki confirmed Thursday that there are discussions to send 2.5 million doses of the AstraZeneca vaccine to Mexico and 1.5 million to Canada.“We are assessing how we can lend doses,” the press secretary said. “That is our aim. It’s not fully finalized yet.”Mexican officials say an agreement among the United States, Canada and Mexico is to be announced Friday.Tens of millions of doses of the Astra Zeneca-University of Oxford vaccine are in U.S. manufacturing sites. That company’s vaccine has been authorized in numerous countries, but not yet in the United States.The AstraZeneca vaccine has received some negative publicity and there is speculation some Americans will hesitate to take that vaccine after it receives expected approval in the United States.Several countries in Europe this week suspended use of the AstraZeneca doses after reports that a few people who received it later developed blot clots and severe bleeding.Europe’s drug regulator Thursday declared the AstraZeneca vaccine safe, adding that a review of the 17 million people who received it found they were actually less likely to develop dangerous clots than others who hadn’t received the vaccine.“It makes sense for the United States to loan its surplus of millions of doses to neighbors where it can be put to good use right away,” said Joshua Busby, assistant professor of public affairs at the University of Texas-Austin.The pending deals with Canada and Mexico, Busby told VOA, do not go far enough because “more countries in the Americas and beyond will need vaccines. But I’m confident that the Biden team is aware of this.”Busby, author of the book Moral Movements and Foreign Policy, said he expects in the coming months the Biden administration will make a major effort to increase global vaccine access “because the longer the epidemic persists globally, the greater the risk of variants that could emerge for which the current vaccines are ineffective.”Asked on Thursday about requests from other countries to make U.S. coronavirus vaccine stock available to them, Psaki replied: “Certainly we’ll have those conversations, and we are open to receiving those requests and obviously making considerations.””Various countries including China have been engaged in so called vaccine diplomacy,” U.S. Secretary of State Antony Blinken told Japanese reporters on Wednesday. “We shouldn’t tie the distribution or access to vaccines to politics or to geopolitics.”Concerns have been raised that the United States and the rest of the West are losing a public relations battle with China and Russia which, at minimum, are using such vaccine distribution to improve their influence and image in developing countries.“Even as nations understandably prioritize their own citizens for vaccines, including their own most vulnerable, we cannot forget that those with the means should also help other countries in need,” said Curtis Chin, former U.S. ambassador to the Asian Development Bank.Vaccine diplomacy competition between nations to help other countries can be a good thing, but “where it falls apart is when that competition overrides necessary cooperation and coordination,” Chin told VOA.
…

your ads here!

As the Northern Hemisphere enters a second spring of the COVID-19 pandemic, experts are saying the higher temperatures and sunnier days are unlikely to do much on their own to curtail the spread of the virus.Travel restrictions and mask mandates, along with people’s behavior, have a much bigger impact than the weather, according to a new report from the World Meteorological Organization (WMO). The report highlights that the steps people can take “far outweigh any external factors, and that’s a really positive thing to know,” said Dev Niyogi, geosciences professor at the University of Texas at Austin, who was not involved in the report but wrote a study published in November with similar findings. “We saw waves of infection rise in warm seasons and warm regions in the first year of the pandemic, and there is no evidence that this couldn’t happen again in the coming year,” Ben Zaitchik, a climate scientist at Johns Hopkins University, said in a statement. Panel to review informationZaitchik chaired an interdisciplinary panel set up by the WMO to make sense of the deluge of research on the issue.When the pandemic began in early 2020, the virus now called SARS-CoV-2 was known simply as the “novel coronavirus.” Scientists could only look to other coronaviruses to guess how this one would behave.Some coronaviruses cause common colds, which rise and fall with the seasons.Scientists do not know exactly why that is, however, the report noted.Some respiratory viruses do not survive as long in a warmer, more humid atmosphere compared with cold, dry winter air. Stronger summer sunlight may zap viruses more with ultraviolet (UV) radiation than on dimmer winter days.In lab studies, SARS-CoV-2 did survive longer in cold, dry conditions with low UV light. But these studies did not show whether those conditions “have a meaningful influence on transmission rates under real-world conditions,” the report said.Affect of weather an unknownOne way the weather could affect how well the virus spreads is by affecting how people behave. Cold weather drives people indoors, where the virus is known to spread more easily. But hot weather and rain can also prompt people to go inside, the report noted.The report also considered how air pollution affected COVID-19, but could not draw firm conclusions on the subject. Some early studies show higher death rates in more polluted air, but they have not been confirmed.While the role of many of these environmental factors are still open questions, the report says the benefit of policies such as travel restrictions and mask mandates “has been clearly established.”Weather and air pollution levels are not a good basis for relaxing these measures, it added.By highlighting how masks and social distancing are more powerful than the weather, the report shows that “for a change, our ability to be exposed or not (to a disease) is in our hands,” Niyogi of the University of Texas said.
…

your ads here!

The European Medicines Agency has approved the continued use of the AstraZeneca COVID-19 vaccine in the battle to contain the pandemic. The European regulator’s seal of approval comes after several European countries, including France, Germany, Italy and Spain, stopped using the vaccine following reports that the shots caused blood clots in some vaccine recipients.The agency said in a statement Thursday “the benefits of the vaccine in combating the still widespread threat of COVID-19 (which itself results in clotting problems and may be fatal) continue to outweigh the risk of side effects.”The agency added, “A causal link with the vaccine is not proven but is possible and deserves further analysis.”Meanwhile, the White House announced Thursday that it is sending millions of stockpiled doses of the AstraZeneca vaccine to Mexico and Canada.The vaccine has not yet been approved for use by U.S. regulators, but it has been approved for use by Mexico and Canada.The announcement comes as the Biden administration wants Mexico’s help in stemming the tide of migrants who are attempting to come into the U.S.Mexico is slated to receive 2.5 million vaccines from the U.S., with Canada receiving 1.5 million.White House press secretary Jen Psaki said the vaccines would be loans to the two U.S. neighbors, with the U.S. eventually being reimbursed with vaccines from the bordering countries.Beginning Friday, several French regions, including Paris, will be under new lockdown orders to contain increasing coronavirus cases.France had 40,000 new cases Wednesday.Prime Minister Jean Castex said Thursday the outbreak in France is “worsening,” adding, “Our responsibility now is that it not get out of control.”On Friday, India’s Union Health Ministry reported an increase in coronavirus infections for a ninth day in a row, with 40,000 new cases in the previous 24-hour period. India has 11.5 million COVID-19 cases.Only two countries have more infections than India — the U.S., with 29.6 million cases, and Brazil, with 11.7 million, according to Johns Hopkins Coronavirus Resource Center.Johns Hopkins reports there are 121.7 million global coronavirus infections.
…

your ads here!

U.S. and Mexican officials deny Washington is attaching any strings to a likely shipment of millions of coronavirus vaccine doses to America’s southern neighbor at a time of heightened migration passing through Mexico en route to the United States.“[P]reventing the spread of a global pandemic is part of one of our diplomatic objectives. Another one of our diplomatic objectives is working to address the challenges at the border. So, it shouldn’t be a surprise that those conversations are both ongoing and happening,” White House press secretary Jen Psaki replied when asked about a link between lending vaccine supplies and commitments from Mexico to tighten the flow of migrants heading north.White House press secretary Jen Psaki speaks during a press briefing at the White House, March 18, 2021, in Washington.“These are two separate issues, as we look for a more humane migratory system and enhanced cooperation against COVID-19, for the benefit of our two countries and the region,” said a statement from Roberto Velasco, director general for the North America region at Mexico’s foreign ministry.Psaki confirmed Thursday that there are discussions to send 2.5 million doses of the AstraZeneca vaccine to Mexico and 1.5 million to Canada.“We are assessing how we can lend doses,” the press secretary said. “That is our aim. It’s not fully finalized yet.”President Joe Biden, accompanied by Vice President Kamala Harris, right, speaks about COVID-19 vaccinations in the East Room of the White House, March 18, 2021, in Washington.In remarks Thursday afternoon, U.S. President Joe Biden announced that the 100 millionth shot of a coronavirus vaccine of his presidency will be administered Friday.The president had previously set a goal of 100 million shots in 100 days. Friday marks the 58th day of his administration.“Scientists have made clear that things may get worse as new variants of this virus spread,” Biden warned. “Getting vaccinated is the best thing we can do to fight back against these variants. Millions of people are vaccinated, we need millions more to be vaccinated.”Biden, in his remarks from the White House East Room, made no mention of sending doses to other countries.Mexican officials say an agreement among the United States, Canada and Mexico is to be announced Friday.Tens of millions of doses of the AstraZeneca-University of Oxford vaccine are in U.S. manufacturing sites. That company’s vaccine has been authorized in numerous countries, but not yet in the United States.Medical workers prepare doses of Oxford/AstraZeneca’s COVID-19 vaccine at a vaccination center in Antwerp, Belgium, March 18, 2021.The AstraZeneca vaccine has received some negative publicity and there is speculation some Americans will hesitate to take that vaccine when it receives expected approval in the United States.Several countries in Europe this week suspended use of the AstraZeneca doses after reports that a few people who received it later developed blot clots and severe bleeding.Europe’s drug regulator Thursday declared the AstraZeneca vaccine safe, adding that a review of the 17 million people who received it found they were actually less likely to develop dangerous clots than others who hadn’t received the vaccine.“It makes sense for the United States to loan its surplus of millions of doses to neighbors where it can be put to good use right away,” said Joshua Busby, assistant professor of public affairs at the University of Texas-Austin.The pending deals with Canada and Mexico, Busby told VOA, do not go far enough because “more countries in the Americas and beyond will need vaccines. But I’m confident that the Biden team is aware of this.”Busby, author of the book “Moral Movements and Foreign Policy,” said he expects in the coming months the Biden administration will make a major effort to increase global vaccine access “because the longer the epidemic persists globally, the greater the risk of variants that could emerge for which the current vaccines are ineffective.”Asked on Thursday about requests from other countries to make U.S. coronavirus vaccine stock available to them, Psaki replied: “Certainly we’ll have those conversations, and we are open to receiving those requests and obviously making considerations.”FILE – In this March 3, 2021, file photo, Secretary of State Antony Blinken speaks on foreign policy at the State Department in Washington.”Various countries including China have been engaged in so called vaccine diplomacy,” U.S. Secretary of State Antony Blinken told Japanese reporters on Wednesday. “We shouldn’t tie the distribution or access to vaccines to politics or to geopolitics.”Concerns have been raised that the United States and the rest of the West are losing a public relations battle with China and Russia which, at minimum, are using such vaccine distribution to improve their influence and image in developing countries.“Even as nations understandably prioritize their own citizens for vaccines, including their own most vulnerable, we cannot forget that those with the means should also help other countries in need,” said Curtis Chin, former U.S. ambassador to the Asian Development Bank.Vaccine diplomacy competition between nations to help other countries can be a good thing, but “where it falls apart is when that competition overrides necessary cooperation and coordination,” Chin told VOA.China termed it disappointing that “some in China’s government and state-controlled media might seek to tear down the vaccine development efforts of other nation’s companies and institution as a response to a call for greater transparency and honesty in China when it comes to COVID-19.”Nearly all countries are participating in the COVAX initiative to deliver coronavirus vaccines to poor countries.The administration of then-President Donald Trump last year declined to join the project because of its association with the World Health Organization, which had lost the his support.Since his inauguration in January, Biden has said the United States would join COVAX and play a more active role globally to fight COVID-19.
…

your ads here!

NASA calls its latest mission on the surface of Mars a “Wright Brothers moment” of aeronautical pioneering. The ISS gets hardware upgrades, and Russia’s lone, female Cosmonaut now has a Barbie doll in her own image. VOA’s Arash Arabasadi brings us the Week in Space.Camera: NASA/AP/ESA/REUTERS/SPACE X/MATTELProduced by: Arash Arabasadi  
…

your ads here!

The World Health Organization’s (WHO) director for Europe said Thursday that the COVID-19 situation in the continent has taken a step backward, with more people dying from the disease than at this time last year.
 
During a virtual briefing from his office in Copenhagen, Hans Kluge told reporters he is particularly concerned about central Europe, the Balkans and the Baltic states, where new cases, hospitalizations and deaths are now among the highest in the world.
 
Kluge said Europe is averaging more than 20,000 deaths from COVID-19 per week, with the overall death toll passing 900,000. He said there were more than 1.2 million new cases reported across Europe last week, the third consecutive week that infection numbers have increased.
 
Kluge said 46 countries in the region have administered more than 107 million doses of the coronavirus vaccine, with 3% of the population in 45 countries having received a completed vaccination series. He said while that represents progress, it is not enough to significantly slow the spread of the virus.
 
“Let there be no doubt about it, vaccination by itself — particularly given the varied uptake in countries — does not replace public health and social measures,” Kluge said.
 
He said 21 European nations are gradually easing COVID-19-related restrictions based on the assumption that increasing vaccinations would immediately lead to an improved epidemiological situation. Kluge added, “Such assumptions are too early to make.”
 
Kluge also weighed in on the AstraZeneca vaccine controversy, in which several countries have suspended its use after reports of patients developing blood clots. He reiterated a statement from WHO officials Wednesday saying the benefits of the vaccine far outweigh its risks, and it should be used.
 
Europe’s drug regulator, the European Medicines Agency, though it issued a similar recommendation earlier this week, is expected to announce the results of a review of the vaccine and the blood clot cases later Thursday.
 
…

your ads here!

Leading United Nations agencies are calling for urgent action to combat ageism, which they say harms the well-being of older people and national economies. The World Health Organization, Office of the High Commissioner for Human Rights, U.N. Department of Economic and Social Affairs and U.N. Population Fund have released the first global report on ageism.A survey of more than 83,000 people in 57 countries finds 1 in every 2 people holds moderately or highly ageist attitudes. Those beliefs are based on stereotypical  ideas about older people drummed into them at an early age.Alana Officer is the World Health Organization’s unit head for demographic change and healthy aging. She says biases start early in life and are reinforced over time. She says ageism is pervasive — in health care systems, in workplaces and in the media.Why Aging of America Poses Huge Risk to US Economy

        Americans are getting older and family size is shrinking, which means the nation will have fewer working-age adults going forward."I think it is a cause for concern if we are calibrating our expectations of having a strongly growing population," says David Kelly, chief global strategist for JP Morgan Asset Management. "If you're investing in things like the housing industry or the auto industry and you need an ever-growing population, then you have to adjust to a world in which the U.S. population is…

She says ageism leads to poorer physical and mental health and to a reduced quality of life for older people. Ageism, she says, determines who receives medical procedures and treatment and who does not. She says age discrimination denies older people jobs and job training.“Half of the world’s population are ageist against older people, which rates much higher in low- and lower middle-income countries …The report indicates that you are likely to be ageist against older people if you are younger, you are male, you are fearful of dying or you are less educated,” Officer said.The report finds women are more likely to be targets of ageism than men. It says younger people also suffer from ageism across many areas, such as employment, health, housing and politics.Vania de la Fuente-Nunez is technical officer in the WHO’s Demographic Change and Healthy Ageing Department. She says the COVID-19 pandemic has revealed how prevalent ageism is against both the young and the old.“Older people have been systematically and homogenously framed as vulnerable and dependent and younger people have been stereotyped as invincible and selfish, which of course fails to recognize the great diversity that we see in both younger people and in older people,” Fuente-Nunez said.She says the stereotypical portrayal in the media is both inaccurate and harmful.The report finds the economic cost of ageism is huge. A 2020 study in the United States shows ageism led to excess annual costs of $63 billion for a broad range of health conditions.Another study in Australia suggests the national economy would be boosted by $37 billion annually if 5% more people aged 55 or older were employed.
…

your ads here!

The European Union’s medications watchdog is due to release initial results Thursday of its investigation into whether there is a connection between the COVID-19 vaccine developed by AstraZeneca and cases of recipients developing blood clots.The European Medicines Agency has been examining 30 reported blood coagulation disorders among the 5 million people in the EU who have received the AstraZeneca vaccine. Among the considerations is whether that rate is more common than the incidence found in the general population.The World Health Organization said Wednesday it is conducting its own assessment of the latest available safety data for the vaccine, but that at this time the agency considers the benefits of the vaccine outweigh its risks.“In extensive vaccination campaigns, it is routine for countries to signal potential adverse events following immunization,” the WHO said in a statement.  “This does not necessarily mean that the events are linked to vaccination itself, but it is good practice to investigate them.”India said Wednesday it would continue using the AstraZeneca vaccine.Concerns about the vaccine prompted a number of EU countries to suspend its use, including Germany, France, Italy and Spain.European Commission President Ursula von der Leyen expressed confidence in AstraZeneca on Wednesday, but continued criticism of the company’s pace of vaccine deliveries.“AstraZeneca has unfortunately under-produced and under-delivered, and this painfully, of course, reduced the speed of the vaccination campaign,” she told reporters.Von der Leyen said the EU is targeting vaccinating 70% of all adults by September.
…

your ads here!

Australia is beginning an urgent rollout of COVID-19 vaccinations in the Torres Strait in northern Queensland because of a sharp increase in infections in neighboring Papua New Guinea, a situation Health Minister Greg Hunt called a “clear and present danger” to both nations.Papua New Guinea, a South Pacific nation of more than 7 million people, is Australia’s nearest neighbor.It’s facing a public health crisis, and in Canberra, Australia Home Affairs Minister Peter Dutton is increasingly worried. Some of Australia’s most northerly islands are just a few kilometers from Papua New Guinea, raising concern the virus could spread easily and quickly across the border.“We do not want the virus sneaking across what is obviously a very small area, and we do not want people in north Queensland, particularly Indigenous communities, facing the incursion of that disease,” he said.Officially, Papua New Guinea has recorded more than 2,300 coronavirus cases since the pandemic began. More than 25 people have died, according to research from Johns Hopkins Coronavirus Resource Center.Australia’s Chief medical officer, professor Paul Kelly, believes the real situation is far worse.“We are seeing a large number of health care workers on the front lines in Papua New Guinea now coming down with COVID-19,” he said. “These are all the signs that there is a major epidemic in the community. They do not have the resources for mass testing as we do here in Australia, and so any number you see coming out of Papua New Guinea in terms of cases and even deaths will be a major underestimate.”Australia is sending 8,000 COVID-19 vaccine doses to its northern neighbor, along with vital supplies for health workers. It is asking the European Union to provide another 1 million doses to help Papua New Guinea. Australian doctors are also starting an urgent vaccination program to protect islanders on the Australian side of the Torres Strait that separates the two nations.The opposition Labor party in Canberra believes Australia has been too slow to react.In Papua New Guinea, Prime Minister James Marape has said COVID-19 has “broken loose” and he warned that hospitals would soon be overwhelmed.His country occupies the eastern half of the island of New Guinea between the Coral Sea and the South Pacific Ocean and lies to the east of Indonesia and to the north of Australia. Agriculture provides a subsistence livelihood for an estimated 85% of the population.
…

your ads here!

Scientists are rethinking the cause of water loss on Mars in the face of new evidence that challenges the long-held theory that the water may have evaporated into space. That’s according to new NASA-funded research published this week in the journal Science.Researchers hypothesize that about 30% and 99% of the water on Mars may have been lost to the crust, likely trapped within the minerals there.The lead author of the study, Eva Scheller, said “the water was lost by 3 billion years ago, meaning Mars has been the dry planet it is today for the past 3 billion years.”Once upon 3 billion years ago, Mars was covered with plentiful water that collected into pools, lakes, and deep oceans about half the volume of Earth’s Atlantic Ocean, researchers concluded based on geological evidence.In search of the missing water, scientists believed water on the Martian crust escaped through the atmosphere because of low gravity on the red planet.Now that theory is being challenged by a new study that theorizes a new model to explain the loss of water.“Atmospheric escape doesn’t fully explain the data that we have for how much water actually once existed on Mars,” she said.Scheller further disclosed that there are three key processes within their model.“Water input from volcanism, water loss to space and water loss to the crust.”She said the model allowed them to match their hydrogen isotope data set in order to calculate the amount of water lost to space and that which was lost to crust.Presenting the study at the 52nd Lunar and Planetary Science Conference, the Caltech Ph.D. candidate explained the research findings are based on the fact that not all hydrogen atoms are the same.There is the most common hydrogen which contains a proton and the less common variant that comprises both proton and neutron. This type is widely referred to as the deuterium or “heavy” hydrogen.When water is lost on a surface, lighter hydrogen atoms defy gravity quicker, leaving behind the “heavy” hydrogen.But the researchers said the amount of the deuterium-to-hydrogen ratio observed in the Martian atmosphere and large amounts of water in the past does not support this theory.
…

your ads here!

Testing is under way for modified versions of COVID-19 vaccines that aim to deal with coronavirus variants. Experts say current vaccines still seem to work against the variants and prevent the most severe forms of disease, though the evidence is limited. Making changes may not be necessary for all the vaccines.  “We don’t know yet,” said Emory University Vaccine Center Associate Director Walter Orenstein. “But people want to get prepared just in case we need to.” Testing and manufacturing will likely take months, he said, so now is the time to get started. All major Western manufacturers with shots in use have announced studies involving either new shots targeted against a specific variant or additional booster shots of their existing vaccines. A woman reacts to seeing a syringe of the Sinovac vaccine for COVID-19 as health workers vaccinate residents in the Kalunga Vao de Almas quilombo on the outskirts of Cavalcante, Goias state, Brazil, March 16, 2021.The A pharmacist prepares to fill a syringe with the AstraZeneca COVID-19 vaccine at the Vaccine Village in Antwerp, Belgium, March 16, 2021.B.1.351 shares mutations with a strain first found in Brazil, where cases are surging. These mutations are thought to help both viruses spread more easily and also make them less susceptible to the effects of the vaccines. A vaccine against one variant may protect against both, said Baylor College of Medicine vaccine expert Peter Hotez. “The hope is that they’ll be close enough that [one variant vaccine] should cross-protect,” he said. “But these studies take time, so we don’t know for certain.” Moderna’s shot was less potent against B.1.351 in test tube studies, but still appeared strong enough to work. The company announced earlier this month that it had A man receives a dose of the Moderna vaccine against the coronavirus, at the Music Auditorium in Rome, Italy, March 17, 2021.Like Moderna’s shot, the Pfizer-BioNTech vaccine suffered in A nurse fills a syringe with a dose of the Pfizer-BioNTech COVID-19 vaccine at Zinga Zanga village hall vaccination center in Beziers, southern France, March 17, 2021.Both the Moderna and Pfizer-BioNTech vaccines are easier to change than earlier types of vaccines, which used dead or weakened germs or germ parts to trigger the immune system. The Moderna and Pfizer-BioNTech shots are genetic recipes for those parts, not the parts themselves.  “It’s relatively straightforward to swap out the genetic recipe for an earlier variant with a newer variant,” said William Moss, executive director of the Johns Hopkins University International Vaccine Access Center. “Technologically, that’s not a big lift.” Booster dose While that remains an option, Pfizer-BioNTech said in February that they are focusing mainly on testing a third, booster dose of their original vaccine. Further strengthening the immune response might overcome a variant’s ability to evade it.  FILE – A health worker loads syringes with the vaccine on the first day of the Johnson & Johnson vaccine being made available to residents at the Baldwin Hills Crenshaw Plaza in Los Angeles. California, March 11, 2021.One of the biggest advantages of this vaccine is that it only requires one dose, while Moderna and Pfizer-BioNTech take two. But Johnson & Johnson announced last November that it was testing the effects of a second dose. The AstraZeneca-University of Oxford vaccine took the biggest hit from B.1.351: just 10% effective against mild to moderate illness in a study published Wednesday. The study did not test how well it works against severe disease and death. Experts expect that it does still provide protection, though that has not been studied yet.  Lead developer Sarah Gilbert at the University of Oxford told the BBC that she expected a modified version against B.1.351 would be ready by late this year. The AstraZeneca vaccine is the one most widely used in the World Health Organization-backed COVAX vaccine distribution program.   The shots are currently on hold in several European countries over concerns about blood clots, though these may be coincidental and unrelated to the vaccine. 
 
…

your ads here!

Mass migration and the COVID-19 pandemic have contributed to the worldwide spread of female genital mutilation, or FGM, executed on girls from infancy to puberty, say aid organizations.Perpetrators cross borders to perform FGM in countries such as Chad, Liberia, Mali, Sierra Leone, Somalia and Sudan, where there is no legislation against the practice, according to research by This map from the University of Virginia Medical School is from 2017 and shows where FGM occurs most in the world.The practice dates back more than 2,000 years and is defined by the World Health Organization (WHO) as the partial or total removal of external female genitalia or other injury to the female genital tissues, including suturing the genitalia. Among the four levels of FGM, some are banned in some countries, while other types remain legal.“In many cases, families are aware that FGM carries a physical and mental health risk, but they have girls undergo FGM to increase their marriageability or as a way of safeguarding their chastity,” said Nankali Maksud, senior adviser of Prevention of Harmful Practices at UNICEF.“While communities cite reasons such as religion, culture or hygiene for practicing FGM, the practice is a human rights violation and an expression of power and control over girls’ and women’s bodies and sexuality,” she said.Despite bans, practice continuesFGM “If a country bans FGM, they’ll usually ban a particular practice of it, so people will just do something else,” said Dena Igusti, a 24-year-old artist and activist from New York who underwent FGM in 2006.“If a country bans FGM, they’ll usually ban a particular practice of it, so people will just do something else,” said Dena Igusti, 24, an artist and activist from New York who underwent FGM in 2006. “If that doesn’t work, they’ll go to a country that’s outwardly against it, like Western countries. But because there isn’t a focus on it, and there is this denial that it happens here, they get away with it.”In early January, the United States tightened its ban on FGM nationally, and it is explicitly banned in 39 states. The U.S. Centers for Disease Control and Prevention estimates that more than 500,000 women and girls have undergone or are at risk of undergoing FGM in the U.S.In all member states of the European Union, FGM is criminalized. But six African nations — Chad, Liberia, Mali, Sierra Leone, Somalia and Sudan — have no laws against FGM, CoP-FGM says.While FGM is banned in the EU, Britain and the United States, it still occurs in these areas. The private nature of the practice and the silencing of victims or their hesitation to come forward continue to make FGM challenging to track.“Because it’s being brought to other places, the thought of it as something that happens in a faraway country doesn’t matter, because if you know someone who can do it, they’ll do it,” Igusti said. “There isn’t protection here. There are legal protections, but it doesn’t really matter.”Some parents travel back to their home countries to administer FGM to their children. Igusti underwent FGM while in Indonesia visiting family.“When it happened, it was kind of out of nowhere,” Igusti said. “My aunt said that we were going to the supermarket, but it was a completely different route. It happened in a way that was painful. I couldn’t walk for a couple of days, and I had gauze stuck in me.Some parents travel back to their home countries to administer FGM to their children. Dena Igusti underwent FGM while in Indonesia visiting family. “It was kind of out of nowhere,” she said.“There’s the physical pain of it, but there’s also the threats of what can happen afterwards. For me, it was always the threat of getting cut again.”Anecdotal evidence shows that when families migrate outside practicing communities, the pressure to conform still compels them to cut their daughters in secret or take them back home, Maksud said.“Discriminatory gender norms, poverty, low levels of education, lack of access to services, poor governance and humanitarian crises may all still lead to girls being cut, even following migration,” she said.Intervention by international organizations to end FGM has been disrupted by COVID-19 lockdowns and travel restrictions, the U.N. Children’s Fund reported in February. Over the next decade, 2 million additional women and girls may undergo this procedure as a result of halted outreach and school closures, the report said.“Before the pandemic, there were educational programs,” said Ann-Marie Wilson, founder and executive director of 28 Too Many, an anti-FGM advocacy group. “Either the funding has stopped for some of the programs, the people delivering the programs have gone away, or the girls aren’t able to access it anymore because of school closures.”Without checks on girls in schools, many have been sent out to work, married off by their parents or sent to work in the sex industry, said Wilson.Wilson said her organization and others like it have had difficulty continuing their FGM intervention programs during the pandemic because of a lack of funding. The group received most of its funds through in-person events. In the first quarter of 2021, 28 Too Many’s income was down by a quarter, according to Wilson.“We’d like to make sure that we do make it through this pandemic and carry on to the future, expanding our work and seeing it into the future,” Wilson said. “We want to work until there is nobody left who has FGM and is vulnerable.”UNICEF adapted its FGM intervention programs to accommodate social distancing during the pandemic by switching to digital media platforms, conducting door-to-door campaigns and conducting community dialogues, according to Maksud.In 2019, the U.N. called for action to eliminate FGM globally by 2030. But with intervention tactics halted by the COVID-19 pandemic, this goal may be out of reach.UN Calls for Ending Female Genital Mutilation by 2030

        Wednesday marks the International Day of Zero Tolerance for Female Genital Mutilation. Coinciding with the day, the United Nations is calling for action to eliminate the procedure by 2030.

The U.N. estimates at least 200 million girls and women alive today have been subjected to female genital mutilation, a procedure that partially or totally removes female genital organs.

“Even before COVID-19 upended progress, the Sustainable Development Goals’ target of ending female genital mutilation by 2030 was an ambitious commitment,” said the report, written by UNICEF Executive Director Henrietta Fore and Natalia Kanem, executive director of the U.N. Population Fund (UNFPA). “Far from dampening our ambition, however, the pandemic has sharpened our resolve to protect the 4 million girls and women who are at risk of female genital mutilation each year.”
   
…

your ads here!

Kenya’s constitutional court has dismissed a petition to strike down the Female Genital Mutilation Act, which outlaws the traditional practice of female circumcision.Women’s rights groups welcomed the ruling and said the judges’ pronouncement would protect millions of women and girls.The 2017 petition sought to invalidate the FGM measure on the ground that it took away a grown woman’s right to undergo the cut.Judge Lydia Achode read the ruling on behalf of the other two judges:”Our final orders shall be as follows: The amended petition is devoid of merit and is hereby dismissed. Two, the attorney general … shall forward a proposal to the national assembly to consider amendment of Section 19 of the prohibition of female genital mutilation … with a view to prohibiting all human practices of FGM as set out in this judgment above.”Sofia Rajab Leteipan, a lawyer with Equality Now, an organization that fights for women’s and girls’ rights, said the ruling had saved women and girls from the practice.”We are extremely pleased with the judgment from the three judges, and I think this judgment goes very far in reaffirming the rights of women and girls to human dignity, to their right to health and also ensuring that we do not use cultural practices as an excuse to undermine the rights of women and girls,” Leteipan said. Law passed decade agoIn 2011, Kenya passed legislation barring female genital mutilation, also called female circumcision. The legislation imposed harsh penalties on those involved in cutting girls and women, including a minimum fine of $1,800 or three years’ imprisonment.Speaking after Wednesday’s ruling, Tatu Kamau, the petitioner, she said she was not happy with the court’s ruling.”Generally for me I am disappointed,” she said. “I feel that the rights of women have been subsumed by those of a child.”Achode disagreed.”We have also discussed the absence of consent by victims. …  We are not persuaded that one can choose to undergo a harmful practice from medical and anecdotal evidence presented by the respondent.  We find that limiting this right is reasonable in an open and democratic society,” the judge said.According to UNICEF, the U.N. children’s agency, more than 200 million women and girls have undergone FGM in 31 countries.  
…

your ads here!